Murata is expanding its range of innovative 6DoF devices with the introduction of the SCH1633-D01 for various automotive ...
A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during ...
Heliogen’s Adjusted EBITDA was $ (11.9) million for the third quarter of 2024, an improvement compared to $ (14.6) million in the second quarter of 2024 and $ (18.8) million in the third quarter of ...
Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting ...
IPS test validation study data will be unveiled at the 2024 SITC Annual Meeting CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback